肾移植与ANCA相关血管炎患者心肌梗死和缺血性卒中风险降低相关:观察性队列研究
该研究基于美国肾脏数据系统2000至2016年因ANCA相关血管炎(AAV)导致终末期肾病(ESRD)的等待名单患者,采用时间依赖Cox模型分析肾移植与心肌梗死或缺血性卒中风险的关联。结果显示,1029例等待名单患者中593例接受移植,移植组事件率为4.6/1000人年,未移植组为13.7/1000人年,肾移植与心肌梗死或缺血性卒中风险降低78%相关(HR=0.22,95%CI 0.11-0.47)。
要点
- 因AAV导致ESRD的等待名单患者中,肾移植与心肌梗死或缺血性卒中风险降低78%相关(HR=0.22)。
- 移植组事件率为4.6/1000人年,未移植组为13.7/1000人年。
- 该关联在性别和年龄组中持续存在,且在活体供肾移植删失后仍存在。
核心结论
- 在因AAV导致ESRD的患者中,肾移植可显著降低心肌梗死和缺血性卒中风险。
- 改善该人群的移植可及性可能进一步改善结局。
研究设计与样本
- 观察性队列研究,使用美国肾脏数据系统2000至2016年因AAV导致ESRD的等待名单患者数据。
- 共纳入1029例等待名单患者,其中593例(58%)在中位随访5.7年间接受肾移植。
- 采用时间依赖Cox比例风险模型,以年龄为时间尺度,估计肾移植与心肌梗死或缺血性卒中事件的HR和95%CI。
主要发现
- 移植组发生17例事件(4.6/1000人年),未移植组发生40例事件(13.7/1000人年)。
- 肾移植与心肌梗死或缺血性卒中风险降低78%相关(HR=0.22,95%CI 0.11-0.47)。
- 该关联在性别和年龄组中持续存在,且在活体供肾移植删失后仍存在。
关键数值与推荐
- 肾移植与心肌梗死或缺血性卒中风险的HR=0.22(95%CI 0.11-0.47)。
- 移植组事件率4.6/1000人年,未移植组事件率13.7/1000人年。
临床怎么用
- 对于因AAV导致ESRD的等待名单患者,肾移植可能显著降低心肌梗死和缺血性卒中风险。
- 应重视改善该人群的移植可及性以改善心血管结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Myocardial infarction and ischemic stroke are leading causes of cardiovascular (CV) morbidity and mortality in ANCA-associated vasculitis (AAV), especially for the 20% with end-stage renal disease (ESRD). We assessed the impact of renal transplantation on the risk of myocardial infarction and stroke among patients with ESRD due to AAV. METHODS: We identified patients from the United States Renal Data System with ESRD due to AAV between 2000 and 2016. We examined the association between renal transplantation and the risk of non-fatal and fatal myocardial infarction or ischemic stroke among waitlisted patients using Medicare claims and death data through 2017. We used time-varying Cox proportional hazards models with age as the time scale to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for myocardial infarction and ischemic stroke events among patients who received a renal transplant compared to those who remained on the waitlist. RESULTS: Of 1029 waitlisted patients, 593 (58%) were transplanted over a mean of 5.7 years. There were 17 events (4.6/1,000 person-years) in the transplanted group and 40 events (13.7/1,000 person-years) in the group that remained waitlisted. A renal transplant was associated with a 78% lower risk of myocardial infarction or ischemic stroke (HR=0.22, 95% CI 0.11 to 0.47). These findings persisted across sex and age groups and when censoring patients after living donor transplantation. CONCLUSIONS: Among AAV patients with ESRD, renal transplantation can substantially reduce the risk of myocardial infarction and ischemic stroke. Improving access to transplantation for this population may further improve outcomes.
引用
- Cook C, Jorge A, Fu X, et al. Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021. PMID: 34600217. doi:10.1016/j.semarthrit.2021.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。